Effects of Isolated Rooms on the Prevalence of Hospital Acquired Pneumonia in a Respiratory ICU
November 30, 2010 updated by: Eskisehir Osmangazi University
Epidemiologic Study of Hospital Acquired Pneumonia in a Respiratory ICU
This study will carry out in the ICU.
Objectives of the study are to determine the frequency of HAP and the effect of isolated rooms on the frequency of pneumonia in the ICU.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In the present study, it was aimed to determine the incidence, causative agents, antimicrobial resistance, and risk factors for lower respiratory tract infections in patients followed in the ICU for the last 4 years.
The effect of reconfiguration from a ward-type ICU consisting one large room to an ICU with isolated rooms with two beds on the incidence of HAP was also determined.
Study Type
Observational
Enrollment (Actual)
532
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Eskisehir, Turkey, 26040
- Eskisehir Osmangazi University
-
-
Merkez
-
Eskisehir, Merkez, Turkey, 26040
- Eskisehir Osmangazi University
-
Eskisehir, Merkez, Turkey, 26040
- Osmangazi University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
All of the patients who had been admitted to the ICU during this period were included in the study
Description
Inclusion Criteria:
- adult patients,
- admitted to the ICU
Exclusion Criteria:
- trauma, surgery or burned patients
- patients under 18
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
hospital acquired pneumonia
|
|
|
isolated rooms
|
frequency of hospital acquired pneumonia in the ICU
Other Names:
|
|
ward-type ICU
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Irfan Ucgun, As.Prof.Dr., Eskisehir Osmangazi University, Medical Faculty
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2004
Primary Completion (Actual)
July 1, 2008
Study Completion (Actual)
August 1, 2010
Study Registration Dates
First Submitted
November 30, 2010
First Submitted That Met QC Criteria
November 30, 2010
First Posted (Estimate)
December 1, 2010
Study Record Updates
Last Update Posted (Estimate)
December 1, 2010
Last Update Submitted That Met QC Criteria
November 30, 2010
Last Verified
January 1, 2004
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HAP-OU-isolation
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.